2 Beaten-Down Artificial Intelligence (AI) Stocks for Contrarian Investors to Consider Buying

The article examines two AI-related stocks that have experienced significant declines: Recursion Pharmaceuticals, an AI-focused biotech company using algorithms for drug discovery with promising candidates but no approved products yet, and Fiverr, a freelance platform shifting strategy toward complex, higher-value projects to counter revenue and user declines. Both present contrarian investment opportunities with substantial upside potential but carry considerable risks.